In animal studies, SMI demonstrated improved cardiac function (LVEF, LVFS) (<i>p</i> < 0.05), and improved heart failure markers (NT-proBNP, <i>p</i> < 0.05) when compared to control groups. The gene discussed is NPPB; the disease is heart failure.